Europe Humanized Mice Model Market By Type (Genetic Humanized Mice Model v/s Cell-Based Humanized Mice Model), By Application (Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Others), By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations), By Country, Competition, Forecast & Opportunities, 2028

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Europe humanized mice model market is expected to witness significant growth during the forecast period 2024-2028. Increasing prevalence of cancer along with the rise in number of research & development activities in pharmaceutical and biotechnology companies are anticipated to facilitate the growth of the market. Moreover, ongoing developments in biological research due to continuous support & initiatives from the governments as well as private sectors are likely to propel the market’s growth. In addition to this, growing demand for personalised medicine are expected to further contribute to market growth. Advances in metabolomics, proteomics, and genomics in the region is creating lucrative growth opportunities in the market. There is a rise in use of humanized mice models in biomedical research including human hematopoiesis, regenerative medicines, transplantation, autoimmunity, and infectious diseases, which is surging the demand for humanised mice model. Moreover, rising government investments and grants plays a key role in strengthening the growth of the market.

 

Growing demand for Personalised Medicine

Personalized medicine is basically tailored medicines which are developed to target individualized treatment and care based on genetic or epigenetic make up and other features. The humanized mice model is treated with large number of drugs or by gene therapies, which help them to find the most suitable treatment. Thus, there is a rise in use of humanized mice model for therapeutic strategies in precision medicine. The increasing research expenditure due to surge in research activities are expected to bolster the growth of the market in the upcoming years. For instance, in 2022, Germany had the highest gross expenditure on research and development (GERD) among European countries, which was 143.1 billion U.S. dollars, followed by France at USD 68.5 billion and then UK at USD 54.9 billion.

 


Download Free Sample Report


Growing Occurrences of Various Diseases

Rising incidences and prevalence of several diseases such as cancer, immunodeficiency disorders, and rare diseases, are anticipated to facilitate the growth of the Europe humanized mice model market.  According to the Global Cancer Observatory, in 2020, there were 47,86,818 number of new cases, out of which 5,76,337 cases were of breast cancer, 5,54,569 cases were of colorectum, 5,34,496 cases were of lung, 5,00,827 cases were of prostate, 2,21,298 cases were of bladder, and 2,399,291 cases of other cancers. The rising prevalence of these diseases are surging the demand for clinical studies, which in turn, use humanized mice model to study the efficacy and safety of immunotherapy approaches. Therefore, supporting the growth of the market.

 

Recent Developments

  • In 2020, The Jackson Laboratory announced the availability of hACE2 transgenic mouse model for coronavirus research. The strategic move assisted the organization in expanding their customer base.
  • In 2019, Taconic Biosciences launched a genetically engineered mice named TRUBIOME.

Market Segmentation

Europe humanized mice model market is segmented into type, application, end user, company, and region. Based on type, the market can be categorized into genetic humanized mice model and cell-based humanized mice model. Cell-based humanized mice model is further classified into CD34 humanized mouse models, PBMC humanized mouse models, and BLT humanized mouse models. Based on application, the market is bifurcated into oncology, immunology & infectious diseases, neuroscience, toxicology, and others. Based on end user, the market is divided into pharmaceutical & biotechnology companies, academic & research institutions, contract research organizations. In terms of countries, the market is divided into Germany, France, United Kingdom, Italy, Spain, Switzerland, Netherland, Poland, Sweden, and Belgium.

 

Market Players

Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., genOway, and Creative Biolabd are some of the leading companies in the market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecastvolume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

Type

Application

End User

Country

Country scope

Germany, France, United Kingdom, Italy, Spain, Switzerland, Netherland, Poland, Sweden, Belgium

Key companies profiled

Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, Creative Biolabd

Customization scope

10% free report customization with purchase. Addition or alteration to country, & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 Report Scope:

In this report, Europe humanized mice model market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Europe Humanized Mice Model Market, By Type:
    • Genetic Humanized Mice Model
    • Cell-Based Humanized Mice Model
      • CD34 Humanized Mouse Models
      • PBMC Humanized Mouse Models
      • BLT Humanized Mouse Models
  • Europe Humanized Mice Model Market, By Application:
    • Oncology
    • Immunology & Infectious Diseases
    • Neuroscience
    • Toxicology
    • Others

·         Europe Humanized Mice Model Market, By End- User:

o   Pharmaceutical & Biotechnology Companies

o   Academic & Research

o   Institutions

o   Contract Research Organizations

·         Europe Humanized Mice Model Market, By Country:

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Switzerland
    • Netherland
    • Poland
    • Sweden
    • Belgium

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Europe humanized mice model market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Europe humanized mice model market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Europe Humanized Mice Model Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Type (Genetic Humanized Mice Model v/s Cell-Based Humanized Mice Model)

5.2.1.1.         By Cell-Based Humanized Mice Model (CD34 Humanized Mouse Models, PBMC Humanized Mouse Models, BLT Humanized Mouse Models)

5.2.2.     By Application (Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Others)

5.2.3.     By End-User (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations)

5.2.4.     By Country

5.2.5.     By Company (2022)

5.3.  Market Map

5.3.1.     By Type

5.3.2.     By Application

5.3.3.     By End-User

5.3.4.     By Country

5.4.  Europe: Country Analysis

5.4.1.     France Humanized Mice Model Market Outlook

5.4.1.1.         Market Size & Forecast

5.4.1.1.1.             By Value

5.4.1.2.         Market Share & Forecast

5.4.1.2.1.             By Type

5.4.1.2.2.             By Application

5.4.1.2.3.             By End User

5.4.2.     Germany Humanized Mice Model Market Outlook

5.4.2.1.         Market Size & Forecast

5.4.2.1.1.             By Value

5.4.2.2.         Market Share & Forecast

5.4.2.2.1.             By Type

5.4.2.2.2.             By Application

5.4.2.2.3.             By End User

5.4.3.     United Kingdom Humanized Mice Model Market Outlook

5.4.3.1.         Market Size & Forecast

5.4.3.1.1.             By Value

5.4.3.2.         Market Share & Forecast

5.4.3.2.1.             By Type

5.4.3.2.2.             By Application

5.4.3.2.3.             By End User

5.4.4.     Italy Humanized Mice Model Market Outlook

5.4.4.1.         Market Size & Forecast

5.4.4.1.1.             By Value

5.4.4.2.         Market Share & Forecast

5.4.4.2.1.             By Type

5.4.4.2.2.             By Application

5.4.4.2.3.             By End User

5.4.5.     Spain Humanized Mice Model Market Outlook

5.4.5.1.         Market Size & Forecast

5.4.5.1.1.             By Value

5.4.5.2.         Market Share & Forecast

5.4.5.2.1.             By Type

5.4.5.2.2.             By Application

5.4.5.2.3.             By End User

5.4.6.     Switzerland Humanized Mice Model Market Outlook

5.4.6.1.         Market Size & Forecast

5.4.6.1.1.             By Value

5.4.6.2.         Market Share & Forecast

5.4.6.2.1.             By Type

5.4.6.2.2.             By Application

5.4.6.2.3.             By End User

5.4.7.     Netherlands Humanized Mice Model Market Outlook

5.4.7.1.         Market Size & Forecast

5.4.7.1.1.             By Value

5.4.7.2.         Market Share & Forecast

5.4.7.2.1.             By Type

5.4.7.2.2.             By Application

5.4.7.2.3.             By End User

5.4.8.     Poland Humanized Mice Model Market Outlook

5.4.8.1.         Market Size & Forecast

5.4.8.1.1.             By Value

5.4.8.2.         Market Share & Forecast

5.4.8.2.1.             By Type

5.4.8.2.2.             By Application

5.4.8.2.3.             By End User

5.4.9.     Sweden Humanized Mice Model Market Outlook

5.4.9.1.         Market Size & Forecast

5.4.9.1.1.             By Value

5.4.9.2.         Market Share & Forecast

5.4.9.2.1.             By Type

5.4.9.2.2.             By Application

5.4.9.2.3.             By End User

5.4.10.  Belgium Humanized Mice Model Market Outlook

5.4.10.1.      Market Size & Forecast

5.4.10.1.1.           By Value

5.4.10.2.      Market Share & Forecast

5.4.10.2.1.           By Type

5.4.10.2.2.           By Application

5.4.10.2.3.           By End User

6.    Market Dynamics

6.1.  Drivers

6.2.  Challenges

7.    Market Trends & Developments

8.    Competitive Landscape

8.1.  Charles River Laboratories, International, Inc.

8.2.  The Jackson Laboratory

8.3.  Gempharmatech Co Ltd

8.4.  Taconic Biosciences, Inc.

8.5.  Envigo (Harlan Laboratories, Inc.)

8.6.  Laboratory Corporation of America Holdings

8.7.  Janvier Labs

8.8.  Trans Genic, Inc.

8.9.  Genoway

8.10.  Creative Biolabd

9. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Growing clinical trials, rising incidences of rare diseases, and increasing R&D activities are driving the demand for the Europe humanized mice model market.

down-arrow

Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, and Creative Biolabd are the key players operating in the Europe humanized mice model market.

down-arrow

On the basis of type, the Europe humanized mice model market the market can be categorized into genetic humanized mice model and cell-based humanized mice model. The genetic humanized mouse model segment is expected to dominate the growth of the market. This is attributed to the wide use of genetic humanized mice models such as for the analysis of compounds, biological efficacy and safety testing.

down-arrow

The high cost of humanized mice model which is restraining the usage in research, which, in turn, are likely to slow down the growth of Europe humanized mice model market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Europe Humanized Mice Model Market to Grow at a Formidable Rate through 2025

Jun, 2020

Rising adoption of mice s for various research studies to drive Europe humanized mice market

Why Choose Us